Total Payments
$2,133
2024 Payments
$577.19
Companies
19
Transactions
52
Medicare Patients
694
Medicare Billing
$139,227
Payment Breakdown by Category
Food & Beverage$2,133 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,133 | 52 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $424.33 | 15 | $0 (2024) |
| Boston Scientific Corporation | $319.30 | 3 | $0 (2022) |
| Penumbra, Inc. | $233.44 | 2 | $0 (2022) |
| Abbott Laboratories | $188.22 | 2 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $150.49 | 3 | $0 (2024) |
| Amgen Inc. | $124.99 | 1 | $0 (2024) |
| CVRx, Inc. | $122.44 | 1 | $0 (2021) |
| GENZYME CORPORATION | $121.84 | 1 | $0 (2024) |
| Allergan, Inc. | $83.00 | 5 | $0 (2020) |
| GlaxoSmithKline, LLC. | $79.38 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $577.19 | 10 | Amgen Inc. ($124.99) |
| 2022 | $558.91 | 6 | Boston Scientific Corporation ($319.30) |
| 2021 | $141.87 | 2 | CVRx, Inc. ($122.44) |
| 2020 | $78.35 | 4 | Penumbra, Inc. ($31.70) |
| 2019 | $162.96 | 9 | Janssen Pharmaceuticals, Inc ($59.00) |
| 2018 | $389.05 | 13 | Abbott Laboratories ($188.22) |
| 2017 | $225.16 | 8 | Janssen Pharmaceuticals, Inc ($126.27) |
All Payment Transactions
52 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: Pulmonology | ||||||
| 09/11/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $29.42 | General |
| 08/29/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $75.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/22/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Bone Health | ||||||
| 07/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: RESPIRATORY | ||||||
| 06/12/2024 | ABBVIE INC. | AVYCAZ (Drug), DALVANCE, TEFLARO | Food and Beverage | In-kind items and services | $23.76 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/07/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $121.84 | General |
| Category: Immunology | ||||||
| 05/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $23.19 | General |
| Category: RESPIRATORY | ||||||
| 05/02/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $120.25 | General |
| Category: Rare Disease | ||||||
| 02/15/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/18/2022 | Penumbra, Inc. | Real Immersive System (Device) | Food and Beverage | Cash or cash equivalent | $201.74 | General |
| Category: Neuro Rehabilitation | ||||||
| 10/05/2022 | Boston Scientific Corporation | General - DBS (Device) | Food and Beverage | In-kind items and services | $120.84 | General |
| Category: General - DBS_NMD | ||||||
| 08/18/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $22.01 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/18/2022 | Boston Scientific Corporation | General - DBS (Device) | Food and Beverage | In-kind items and services | $139.46 | General |
| Category: General - DBS_NMD | ||||||
| 02/05/2022 | Boston Scientific Corporation | General - DBS (Device) | Food and Beverage | In-kind items and services | $59.00 | General |
| Category: General - DBS_NMD | ||||||
| 02/02/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/05/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/30/2021 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | In-kind items and services | $122.44 | General |
| Category: Heart Failure and Hypertension | ||||||
| 07/08/2020 | Penumbra, Inc. | REAL System (Device) | Food and Beverage | Cash or cash equivalent | $31.70 | General |
| Category: Neuro Rehabilitation | ||||||
| 03/11/2020 | Allergan, Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: ANTI-INFECTIVE | ||||||
| 02/13/2020 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $11.82 | General |
| Category: Cardiovascular | ||||||
| 01/09/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/13/2019 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $18.10 | General |
| 10/10/2019 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/11/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 441 | 932 | $275,543 | $75,180 |
| 2022 | 3 | 95 | 359 | $60,865 | $21,711 |
| 2021 | 3 | 130 | 558 | $93,750 | $33,866 |
| 2020 | 2 | 28 | 148 | $26,345 | $8,471 |
Total Patients
694
Total Services
1,997
Medicare Billing
$139,227
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 65 | 289 | $46,730 | $17,989 | 38.5% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 51 | 141 | $26,790 | $11,782 | 44.0% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 71 | 131 | $24,570 | $11,104 | 45.2% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 50 | 50 | $14,800 | $7,188 | 48.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Office | 2023 | 16 | 116 | $15,642 | $7,183 | 45.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 62 | 62 | $16,981 | $6,359 | 37.4% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Office | 2023 | 22 | 25 | $7,630 | $3,594 | 47.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 48 | 48 | $8,293 | $3,076 | 37.1% |
| 99349 | Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes | Office | 2023 | 19 | 30 | $6,600 | $3,016 | 45.7% |
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 11 | 14 | $102,690 | $1,701 | 1.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Office | 2023 | 14 | 14 | $3,137 | $1,423 | 45.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Office | 2023 | 12 | 12 | $1,680 | $766.56 | 45.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 41 | 303 | $48,600 | $17,074 | 35.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 28 | 29 | $7,540 | $3,087 | 40.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 26 | 27 | $4,725 | $1,549 | 32.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 60 | 481 | $76,960 | $27,460 | 35.7% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 35 | 39 | $10,140 | $4,207 | 41.5% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 35 | 38 | $6,650 | $2,199 | 33.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 17 | 137 | $24,120 | $7,833 | 32.5% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 11 | 11 | $2,225 | $638.41 | 28.7% |
About Dr. Mansour Mofidi, DO
Dr. Mansour Mofidi, DO is a Internal Medicine healthcare provider based in La Mesa, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1164598843.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mansour Mofidi, DO has received a total of $2,133 in payments from pharmaceutical and medical device companies, with $577.19 received in 2024. These payments were reported across 52 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($2,133).
As a Medicare-enrolled provider, Mofidi has provided services to 694 Medicare beneficiaries, totaling 1,997 services with total Medicare billing of $139,227. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location La Mesa, CA
- Active Since 11/27/2006
- Last Updated 12/19/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1164598843
Products in Payments
- XARELTO (Drug) $349.54
- General - DBS (Device) $319.30
- Real Immersive System (Device) $201.74
- CardioMEMS HF System (Device) $188.22
- EVENITY (Biological) $124.99
- Barostim Neo System (Device) $122.44
- DUPIXENT (Biological) $121.84
- ANDEXXA (Biological) $120.25
- INVOKANA (Drug) $74.79
- AVYCAZ (Drug) $72.51
- CRESEMBA (Drug) $48.02
- TRELEGY ELLIPTA (Drug) $43.71
- ENTRESTO (Drug) $40.69
- DALVANCE (Drug) $34.25
- REAL System (Device) $31.70
- BRILINTA (Drug) $30.24
- PRADAXA (Drug) $26.80
- ELIQUIS (Drug) $25.95
- OFEV (Drug) $23.19
- ANORO (Drug) $18.17
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in La Mesa
Lee Katzman, M.d, M.D
Internal Medicine — Payments: $24,895
Internal Medicine $24,895
Raed Al-Naser, M.d, M.D
Internal Medicine — Payments: $20,951
Internal Medicine $20,951
Dr. Payam Mehranpour, M.d, M.D
Internal Medicine — Payments: $17,294
Internal Medicine $17,294
Barzan Mohedin, Md, MD
Internal Medicine — Payments: $15,368
Internal Medicine $15,368
Elahe Toulouie, M.d, M.D
Internal Medicine — Payments: $11,475
Internal Medicine $11,475
Mr. Michael Lajin, M.d, M.D
Internal Medicine — Payments: $10,784
Internal Medicine $10,784